Transitional cell carcinoma of the kidney is a type of cancer that originates from the transitional cells that line the renal pelvis and the ureter. The ureter is the tube that connects the kidneys to the bladder while the ureter is the duct where urine passes through from the kidney to the bladder. Patients with transitional cell carcinoma of the kidney suffer from various symptoms especially when the disease is already in the advanced stage. These symptoms include persistent back pain, blood in the urine, fatigue, unexplained weight loss, and frequent, painful urination.
Because the condition shares the same symptoms with other health conditions, it is very common for patients to be misdiagnosed, which leads to delayed treatment.
Patients who want to receive immediate, accurate diagnosis may consult a nephrologist or kidney specialist in Southeast Asian countries such as Singapore, Thailand, and Malaysia. The region is home to internationally trained nephrologists who have easy access to sophisticated diagnostic tools. These specialists perform ureteroscopy, intravenous pyelogram, ultrasound of the abdomen, magnetic resonance imaging (MRI), CT scan of the kidneys and bladder, and biopsy of the cells from the renal pelvis or ureter to accurately assess the patient’s condition.
Because nephrologists in Southeast Asia have access to sophisticated and cutting-edge diagnostic and surgical equipment, they can offer patients, both local and international, various treatment options based on their resources and preferences. These include minimally invasive surgical procedures such as endoscopic resection or laser surgery that do not require a long incision. Thus, patients recover faster and experience less intraoperative and postoperative pain. In advanced cases where the part of the ureter needs to be resected or removed, surgeons in Southeast Asia can also perform segmental resection and nephroureterectomy. Patients are also treated with chemotherapy and biological therapies following any surgical procedure to kill remaining cancer cells.
Patients who take advantage of comprehensive treatment for transitional cell carcinoma of the kidney in Southeast Asia can expect the same quality of care offered in Western countries such as the United States and United Kingdom. However, they do not have to pay thousands of dollars for it because diagnostics as well as medical and surgical services in Singapore, Thailand, and Malaysia are up to 75% cheaper than in Western countries.